Sanofi Offloads Two German OTC Brands, New CEO Prepares To Make Mark

04 Sep 2019

Sanofi's push to concentrate its Consumer Healthcare portfolio on priority categories sees it offload two OTC brands in Germany and Austria. Meanwhile, new Sanofi CEO Paul Hudson has spoken about his intention to review the firm's plans in the OTC market.

A professional businessman thinking while standing on a black arrow pointing forward in grey space concept

Sanofi has divested two OTC brands to Italy’s Angelini SPA in a deal worth €47m ($51m). The French firm signaled earlier this year that it would continue to rationalize its Consumer Healthcare portfolio to focus its efforts around a number of priority brands and categories. (Also see "Sanofi Plans Further Consumer Health Divestments As It Reports Slow Start To Year" - HBW Insight, 29 April, 2019.)

Angelini has picked up the BoxaGrippal (ibuprofen/pseudoephedrine) cold and flu brand and the Heumann range of medicinal teas indicated to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’

09 Aug 2025

• By Malcolm Spicer

PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.

Navamedic To Market OTC Naloxone In Norway Following Switch

21 Jul 2025

• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

18 Jul 2025

• By Tom Gallen

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

14 Jul 2025

• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

06 Aug 2025

• By Malcolm Spicer

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.